ArticleAmerican journal of lifestyle medicine2025
Implementing Lifestyle Medicine in Cancer Survivorship: A Narrative Review of Global Models.
Article in American journal of lifestyle medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Colorectal Cancer: Epidemiology, Risk Factors, Signaling Pathways, Clinical Features, Screening, Diagnosis, and Management.MedComm · 2026Review
- Moving beyond cancer survivorship: longevity medicine.BMJ supportive & palliative care · 2026Article
- A randomized trial of a multimodal lifestyle intervention in cancer survivors.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular disease and cancer are the leading causes of mortality in developed countries. Advances in screening and treatment have led to a growing population of cancer survivors who require long-term supportive care. Many experience persistent health challenges, including fatigue, functional decline, and cardiometabolic comorbidities. Lifestyle medicine, which includes nutrition, physical activity, stress management, sleep, social connections, and risk reduction, provides a structured approach to optimizing survivorship outcomes.This narrative review examines the role of Lifestyle Medicine in oncology and highlights global implementation models. Programs analyzed include the Mass General Cancer Center's Lifestyle Medicine Clinic, the Clinical Oncology Society of Australia's exercise oncology framework, the Cleveland Clinic Abu Dhabi's Lifestyle Medicine Oncology Program, and Kansas City's community-based Cancer Wellness for Life initiative. Across diverse clinical settings, structured lifestyle interventions have been associated with improved treatment tolerance, quality of life, and the potential to reduce cardiometabolic risk factors. Hospital-based programs integrate multidisciplinary support, while community-driven initiatives expand access to lifestyle interventions. Despite strong evidence supporting these approaches, barriers to widespread adoption include gaps in clinician training, limited institutional support, and disparities in patient access. Global models show the feasibility and advantages of integrating Lifestyle Medicine into survivorship care. Increasing access, overcoming implementation challenges, and using technology can improve survivorship outcomes. Including Lifestyle Medicine in standard oncology care can improve long-term health and encourage survivors to manage their well-being actively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.